In The Know with DenseBreast-info Quiz #5
The latest quiz in the collaborative series with OBG Management magazine is now live. Each month’s quiz addresses a knowledge gap identified through the DB-i research study, Effect of an educational intervention on women’s healthcare provider knowledge gaps about breast density, breast cancer risk, and screening. Please share these within your referring provider network.
- Quiz #1, How is a woman determined to have dense breast tissue?
- Quiz #2, True or false: Breast density increases breast cancer risk
- Quiz #3, In which categories of breast density does tomosynthesis/3D mammography increase cancer detection over standard digital mammography?
- Quiz #4, Average-risk women with dense breasts—What breast screening is appropriate?
- Quiz #5, Your 28-year-old patient has a first-degree relative with a known disease-causing BRCA1 or BRCA2 mutation, but she herself has not been tested. Which breast screening method(s) should you recommend?
DB-i/Europe
Welcome! Prof. Mark F. McEntee, from the Republic of Ireland, has joined DB-i/Europe as a European Education Supporter. Our Education Supporters advance education on the implications of dense breast tissue and support DB-I/Europe content and resources.
Professor McEntee is Head of Medical Imaging and Radiation Therapy at University College Cork; mammography is among his varied research interests. He has published several popular papers on the measurement of breast density in digital mammography and digital breast tomosynthesis. His work has established Dose Reference Levels for Mammography in New South Wales and he has proposed new methods of calculating breast dose using the actual breast density of the patient rather than the mean glandular dose (MGD).